Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cerna

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Molecular Biology|July 30, 2005
The structure of Sif2p, a WD repeat protein functioning in the SET3 corepressor complexDavid Cerna, David K Wilson
Current Topics in Developmental Biology|June 20, 2006
Histone deacetylation as a target for radiosensitizationDavid Cerna, Kevin Camphausen, Philip J Tofilon
The Journal of Biological Chemistry|January 13, 2005
The 1.1-angstrom structure of the spindle checkpoint protein Bub3p reveals functional regionsDavid K Wilson, David Cerna, Erin Chew
Cancer Research|August 3, 2005
ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibitionHideaki Dote, David Cerna, William E Burgan, et al.
Molecular Cancer Research : MCR|November 24, 2012
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapyAdeola Y Makinde, Molykutty John-Aryankalayil, Sanjeewani T Palayoor, et al.
The Journal of Biological Chemistry|May 10, 2012
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent mannerDavid Cerna, Hongyun Li, Siobhan Flaherty, et al.
International Journal of Cancer|August 30, 2008
PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cellsSanjeewani T Palayoor, James B Mitchell, David Cerna, et al.
Molecular Cancer Therapeutics|January 14, 2009
NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cellsMolykutty John-Aryankalayil, Sanjeewani T Palayoor, David Cerna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Postradiation sensitization of the histone deacetylase inhibitor valproic acidPrakash Chinnaiyan, David Cerna, William E Burgan, et al.
International Journal of Cancer|December 4, 2004
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acidKevin Camphausen, David Cerna, Tamalee Scott, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Molecular Biology|July 30, 2005
The structure of Sif2p, a WD repeat protein functioning in the SET3 corepressor complexDavid Cerna, David K Wilson
Current Topics in Developmental Biology|June 20, 2006
Histone deacetylation as a target for radiosensitizationDavid Cerna, Kevin Camphausen, Philip J Tofilon
The Journal of Biological Chemistry|January 13, 2005
The 1.1-angstrom structure of the spindle checkpoint protein Bub3p reveals functional regionsDavid K Wilson, David Cerna, Erin Chew
Cancer Research|August 3, 2005
ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibitionHideaki Dote, David Cerna, William E Burgan, et al.
Molecular Cancer Research : MCR|November 24, 2012
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapyAdeola Y Makinde, Molykutty John-Aryankalayil, Sanjeewani T Palayoor, et al.
The Journal of Biological Chemistry|May 10, 2012
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent mannerDavid Cerna, Hongyun Li, Siobhan Flaherty, et al.
International Journal of Cancer|August 30, 2008
PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cellsSanjeewani T Palayoor, James B Mitchell, David Cerna, et al.
Molecular Cancer Therapeutics|January 14, 2009
NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cellsMolykutty John-Aryankalayil, Sanjeewani T Palayoor, David Cerna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Postradiation sensitization of the histone deacetylase inhibitor valproic acidPrakash Chinnaiyan, David Cerna, William E Burgan, et al.
International Journal of Cancer|December 4, 2004
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acidKevin Camphausen, David Cerna, Tamalee Scott, et al.
Pageof 2